Liver microwave ablation: a systematic review of various FDA-approved systems

Simeon J. S. Ruiter; Wouter J. Heerink; Koert P. de Jong

doi:10.1007/s00330-018-5842-z

Liver microwave ablation: a systematic review of various FDA-approved systems

Simeon J. S. Ruiter, Wouter J. Heerink, Koert P. de Jong

Groningen Institute for Organ Transplantation (GIOT)

Research output: Contribution to journal › Review article › peer-review

74 Citations (Scopus)

523 Downloads (Pure)

Abstract

ObjectivesThe aim of the present study is to analyze preclinical and clinical data on the performance of the currently US Food and Drug Administration (FDA)-approved microwave ablation (MWA) systems.MethodsA review of the literature, published between January 1, 2005, and December 31, 2016, on seven FDA-approved MWA systems, was conducted. Ratio of ablation zone volume to applied energy R(AZ:E) and sphericity indices were calculated for ex vivo and in vivo experiments.ResultsThirty-four studies with ex vivo, in vivo, and clinical data were summarized. In total, 14 studies reporting data on ablation zone volume and applied energy were included for comparison R(AZ:E). A significant correlation between volume and energy was found for the ex vivo experiments (r=0.85, p

Original language	English
Pages (from-to)	4026-4035
Number of pages	10
Journal	European Radiology
Volume	29
Issue number	8
Early online date	30-Nov-2018
DOIs	https://doi.org/10.1007/s00330-018-5842-z
Publication status	Published - Aug-2019

Keywords

Microwaves
Ablation techniques
Electromagnetic radiation
Tumor volume
Liver diseases
EX-VIVO BOVINE
VENOUS-BLOOD FLOW
IN-VIVO
THERMOSPHERE ABLATION
HEPATOCELLULAR-CARCINOMA
RADIOFREQUENCY ABLATION
REPORTING CRITERIA
THERMAL ABLATION
DEVICES
ENERGY

Access to Document

10.1007/s00330-018-5842-zLicence: CC BY

Liver microwave ablation: a systematic review of various FDA-approved systemsFinal publisher's version, 653 KBLicence: CC BY

Handle.net

Persistent link

Cite this

@article{c8e4bd662c15449f89c8bc238ad4eb63,

title = "Liver microwave ablation: a systematic review of various FDA-approved systems",

abstract = "ObjectivesThe aim of the present study is to analyze preclinical and clinical data on the performance of the currently US Food and Drug Administration (FDA)-approved microwave ablation (MWA) systems.MethodsA review of the literature, published between January 1, 2005, and December 31, 2016, on seven FDA-approved MWA systems, was conducted. Ratio of ablation zone volume to applied energy R(AZ:E) and sphericity indices were calculated for ex vivo and in vivo experiments.ResultsThirty-four studies with ex vivo, in vivo, and clinical data were summarized. In total, 14 studies reporting data on ablation zone volume and applied energy were included for comparison R(AZ:E). A significant correlation between volume and energy was found for the ex vivo experiments (r=0.85, p",

keywords = "Microwaves, Ablation techniques, Electromagnetic radiation, Tumor volume, Liver diseases, EX-VIVO BOVINE, VENOUS-BLOOD FLOW, IN-VIVO, THERMOSPHERE ABLATION, HEPATOCELLULAR-CARCINOMA, RADIOFREQUENCY ABLATION, REPORTING CRITERIA, THERMAL ABLATION, DEVICES, ENERGY",

author = "Ruiter, {Simeon J. S.} and Heerink, {Wouter J.} and {de Jong}, {Koert P.}",

year = "2019",

month = aug,

doi = "10.1007/s00330-018-5842-z",

language = "English",

volume = "29",

pages = "4026--4035",

journal = "European Radiology",

issn = "1432-1084",

publisher = "Springer",

number = "8",

}

TY - JOUR

T1 - Liver microwave ablation

T2 - a systematic review of various FDA-approved systems

AU - Ruiter, Simeon J. S.

AU - Heerink, Wouter J.

AU - de Jong, Koert P.

PY - 2019/8

Y1 - 2019/8

N2 - ObjectivesThe aim of the present study is to analyze preclinical and clinical data on the performance of the currently US Food and Drug Administration (FDA)-approved microwave ablation (MWA) systems.MethodsA review of the literature, published between January 1, 2005, and December 31, 2016, on seven FDA-approved MWA systems, was conducted. Ratio of ablation zone volume to applied energy R(AZ:E) and sphericity indices were calculated for ex vivo and in vivo experiments.ResultsThirty-four studies with ex vivo, in vivo, and clinical data were summarized. In total, 14 studies reporting data on ablation zone volume and applied energy were included for comparison R(AZ:E). A significant correlation between volume and energy was found for the ex vivo experiments (r=0.85, p

AB - ObjectivesThe aim of the present study is to analyze preclinical and clinical data on the performance of the currently US Food and Drug Administration (FDA)-approved microwave ablation (MWA) systems.MethodsA review of the literature, published between January 1, 2005, and December 31, 2016, on seven FDA-approved MWA systems, was conducted. Ratio of ablation zone volume to applied energy R(AZ:E) and sphericity indices were calculated for ex vivo and in vivo experiments.ResultsThirty-four studies with ex vivo, in vivo, and clinical data were summarized. In total, 14 studies reporting data on ablation zone volume and applied energy were included for comparison R(AZ:E). A significant correlation between volume and energy was found for the ex vivo experiments (r=0.85, p

KW - Microwaves

KW - Ablation techniques

KW - Electromagnetic radiation

KW - Tumor volume

KW - Liver diseases

KW - EX-VIVO BOVINE

KW - VENOUS-BLOOD FLOW

KW - IN-VIVO

KW - THERMOSPHERE ABLATION

KW - HEPATOCELLULAR-CARCINOMA

KW - RADIOFREQUENCY ABLATION

KW - REPORTING CRITERIA

KW - THERMAL ABLATION

KW - DEVICES

KW - ENERGY

U2 - 10.1007/s00330-018-5842-z

DO - 10.1007/s00330-018-5842-z

M3 - Review article

SN - 1432-1084

VL - 29

SP - 4026

EP - 4035

JO - European Radiology

JF - European Radiology

IS - 8

ER -

Liver microwave ablation: a systematic review of various FDA-approved systems

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this